Suzanne M. Kelly

Papers

Total Citations

H-Index

About

Suzanne M. Kelly is a clinical researcher focused on improving the precision of lung cancer radiotherapy through advanced bronchoscopic techniques. Her primary research areas include electromagnetic navigational bronchoscopy (ENB), fiducial marker placement, and respiratory motion management for stereotactic ablative radiotherapy (SABR). Kelly’s major contribution is the development of a novel fiducial marker placement guidance system that significantly enhances respiratory motion tracking during ENB. This innovation addresses a critical challenge in treating early-stage non-small cell lung cancer (NSCLC) and oligometastatic disease, where tumor movement due to breathing can compromise treatment accuracy. Her most-cited work (2019, 5 citations) demonstrates how improved marker placement reduces motion-related errors, enabling more precise SABR delivery. An earlier study (2017, 2 citations) laid the groundwork for this approach. While her citation counts are modest, Kelly’s work represents a practical advancement in image-guided interventions, directly impacting patient outcomes by minimizing damage to healthy tissue. Her research bridges interventional pulmonology and radiation oncology, offering a tangible solution for non-surgical candidates. Kelly’s contributions are particularly notable for their clinical applicability, providing a foundation for future studies in motion-compensated radiotherapy.